MEREDITH COOK: Open Payments
NPI 1366958555 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,082 in 69 payments from 11 companies in 2025. Trend: 2023 $635 · 2024 $1,105 · 2025 $2,082
Food & beverage: $2,082
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 11 | $498 |
| Gilead Sciences, Inc. | 15 | $428 |
| Ipsen Biopharmaceuticals, Inc | 10 | $279 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $232 |
| Intercept Pharmaceuticals, Inc. | 10 | $174 |
| Mirum Pharmaceuticals, Inc. | 2 | $173 |
| Novo Nordisk Inc | 2 | $129 |
| GlaxoSmithKline, LLC. | 1 | $57 |
| Eton Pharmaceuticals, Inc. | 1 | $45 |
| ORPHALAN INC | 2 | $43 |
Products named: REZDIFFRA, IQIRVO, XIFAXAN, OCALIVA, Livmarli, Wegovy, ALKINDI, CUVRIOR.
Industry payments across TX — which companies pay providers there.
